Acciones Teva Pharmaceutical Industries Limited TEL AVIV STOCK EXCHANGE
Acciones
IL0006290147
Farmacéuticos
Ventas 2024 * | 15,92 mil M 59,3 mil M 14,78 mil M | Ventas 2025 * | 16,49 mil M 61,42 mil M 15,31 mil M | Capitalización | 18,12 mil M 67,5 mil M 16,83 mil M |
---|---|---|---|---|---|
Resultado Neto 2024 * | 820 M 3054,42 M 761 M | Resultado Neto 2025 * | 1387 M 5166,44 M 1287,76 M | VE / Ventas 2024 * | 2,08 x |
Deuda neta 2024 * | 14,93 mil M 55,59 mil M 13,86 mil M | Deuda neta 2025 * | 12,41 mil M 46,22 mil M 11,52 mil M | VE / Ventas 2025 * | 1,85 x |
P/E ratio 2024 * |
17
x | P/E ratio 2025 * |
11,9
x | Empleados | - |
Rendimiento 2024 * |
-
| Rendimiento 2025 * |
-
| Flotante | 89,71 % |
Último transcript sobre Teva Pharmaceutical Industries Limited
Directores | Puesto | Edad | Desde |
---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 01/01/23 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 22/12/19 |
Eric Hughes
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/22 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 01/09/15 |
Janet Vergis
BRD | Director/Board Member | 59 | 09/06/20 |
Sol Barer
CHM | Chairman | 76 | 01/01/15 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+30,86 % | 695 mil M | |
+26,51 % | 568 mil M | |
-4,70 % | 361 mil M | |
+19,65 % | 330 mil M | |
+3,91 % | 283 mil M | |
+16,70 % | 239 mil M | |
+8,78 % | 204 mil M | |
-7,93 % | 198 mil M | |
+7,65 % | 168 mil M |